Rational use of Xpert testing in patients with presumptive TB: clinicians should be encouraged to use the test-treat threshold
Abstract Background A recently published Ugandan study on tuberculosis (TB) diagnosis in HIV-positive patients with presumptive smear-negative TB, which showed that out of 90 patients who started TB treatment, 20% (18/90) had a positive Xpert MTB/RIF (Xpert) test, 24% (22/90) had a negative Xpert te...
Main Authors: | Tom Decroo, Aquiles R. Henríquez-Trujillo, Anja De Weggheleire, Lutgarde Lynen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-10-01
|
Series: | BMC Infectious Diseases |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12879-017-2798-6 |
Similar Items
-
Treatment decisions and mortality in HIV-positive presumptive smear-negative TB in the Xpert® MTB/RIF era: a cohort study
by: Sabine M. Hermans, et al.
Published: (2017-06-01) -
Upfront Xpert MTB/RIF testing on various specimen types for presumptive infant TB cases for early and appropriate treatment initiation.
by: Neeraj Raizada, et al.
Published: (2018-01-01) -
Chest Radiography and Xpert MTB/RIF® Testing in Persons with Presumptive Pulmonary TB: Gaps and Challenges from a District in Karnataka, India
by: Manjula Kanakaraju, et al.
Published: (2020-01-01) -
Enhancing TB case detection: experience in offering upfront Xpert MTB/RIF testing to pediatric presumptive TB and DR TB cases for early rapid diagnosis of drug sensitive and drug resistant TB.
by: Neeraj Raizada, et al.
Published: (2014-01-01) -
Should treatment of low-level rifampicin mono-resistant tuberculosis be different?
by: Armand Van Deun, et al.
Published: (2021-05-01)